Rethinking phase 2 trials in amyotrophic lateral sclerosis is a research paper published in Brain (2024). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
NIH HHS
National Institutes of Health
NIH HHS
FWCI
3.02
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords